Prostate Health Supplement

Super Beta Prostate

1,108 adverse event reports submitted to the FDA · 2012–2021 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 1,108 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Blood urine present

268

Haemorrhage

Haematochezia

Urinary retention

Blood pressure increased

Dyspnoea

Cerebrovascular accident

Dizziness

Myocardial infarction

Malaise

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Other Serious or Important Medical Event	895
Hospitalization	341
Visited Emergency Room	181
Visited a Health Care Provider	169
Other Serious Outcome	116
Life Threatening	20
Required Intervention	2
Death	2
Disability	1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

50–64

163

65–79

251

80+

101

Unknown

580

528 reports had age data; 580 unknown.

Gender

Male

1,014

Unknown/Not Reported

Female

Reports by Year

Annual report counts from 2012–2021. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

Hover bars for exact counts.

← View all Super Beta products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology